Westend S.A. - Insider Non-Derivative Transactions at LEXICON PHARMACEUTICALS, INC. (LXRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 5, 2023, Westend S.A.'s relationship to LEXICON PHARMACEUTICALS, INC. (LXRX) is Director,TenPercentOwner, and currently has 78,634,381 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LXRX insiders.
Data Source: SEC.
Westend S.A. - Insider Non-Derivative Transactions at LXRX
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 6, 2023 | P -- (Common Stock) | 27,775,050 | 2.6 | 78,634,381 |
Items per page:
1 – 1 of 1